The funding round was led by Valtruis, The Cigna Group Ventures, and Tau Ventures, with continued participation from existing investors Asset Management Ventures, ATX Venture Partners, and Capital Factory. The company will use the funding to accelerate its mission to rewire healthcare operations through its proprietary Agentic AI Orchestration platform, designed to reduce administrative burdens and improve care delivery.
Ganesh Padmanabhan, CEO and co-founder of Autonomize AI, emphasized the need for change in a system that is increasingly strained: “The current healthcare system is no longer suited for the way care is delivered today—and too often, patients and clinicians pay the price in delayed treatment, wasted time, and unnecessary friction. Automation alone is not the answer for healthcare, but accountable, human-centered AI augmentation is. This funding will help us scale our platform to solve some of the most frustrating, high-impact operational challenges in healthcare, while keeping patients and care outcomes at the center.”
What sets Autonomize AI apart is its healthcare-native approach to AI orchestration. Unlike generic generative AI platforms, Autonomize AI deploys pre-trained, ready-to-use AI agents capable of managing complex, regulated workflows such as care management, utilization review, benefits checks, and chart reviews. These intelligent Copilots work in coordination as part of a multi-agent system that understands and adapts to the intricate processes within healthcare operations.
“There’s never been a more important time to apply AI in healthcare,” said Mike Spadafore, Managing Director at Valtruis. “Healthcare operators are ready, but they need partners who understand real workflows and can deliver results at scale. That takes more than technical talent — it requires deep knowledge of how care is delivered and paid for. Autonomize AI gets that. Their platform enables healthcare operators to quickly deploy and scale AI agents across high-impact use cases — and they’re already driving real results at some of the country’s largest healthcare organizations. We’re excited for the opportunity to partner with them.”
The platform’s impact is already visible in real-world deployments. Autonomize AI is saving 36,000 clinical hours per month by automating repetitive administrative tasks, creating over 100,000 automated care plans monthly, and enabling up to 50% faster prior authorization and claims decisions. These results translate into more time for care providers to focus on patient interaction and faster access to care for patients.
Craig Cimini, Head of The Cigna Group Ventures, underscored the alignment between the company’s mission and Autonomize AI’s technology: “Autonomize AI’s vision for augmenting, not replacing, the people who power healthcare is one we share. We see tremendous potential in the company’s platform to drive scalable, responsible innovation in healthcare operations while ensuring patients and providers remain at the center of care.”
Founded in 2022 by Ganesh Padmanabhan and Kris Nair, Autonomize AI has quickly gained traction across various sectors in healthcare and life sciences. Its technology is built with enterprise-wide orchestration, explainability, human-in-the-loop design, and regulatory compliance at its core. As the company continues to scale, it is one of the few AI platforms delivering measurable impact across clinical, operational, and financial metrics in real-time healthcare environments.
